INDICATION
Internal Medicine/Women’s Health
AGE CRITERIA
DESCRIPTION
High Triglycerides with Diabetes.
Male ≥ 50 y/o Female ≥ 55 yrs. old
Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides in patients with diabetes (PROMINENT).
Endometriosis
≥ 18 yrs. old
A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain.
Endometriosis
≥ 18 yrs. old
“A Prospective Cohort Study to Assess Bone Mineral Density in Subjects Receiving Standard of Care Treatment for Endometriosis”.
Uterine Fibroids
≥ 18 yrs. old
A Phase 3b Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women.
Asthma
≥ 18 yrs. old
A Randomized, Double-Blind, Parallel Group, Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistent Asthma.